13 Nov 2024
AHA 2024: get the interventional cardiology perspective!
Condensed take-home messages from the American Heart Association Scientific Sessions 2024
Stay up to date with what is new and hot in interventional cardiology at #AHA24 in Chicago.
Mirvat Alasnag, Luis Ortega Paz, Alex Sticchi and Edoardo Zancanaro will provide their take on a selection of major late-breaking trials and studies of interest to the interventional cardiology community presented at AHA 2024!
- OPTION: Left Atrial Appendage Closure after Ablation for Atrial Fibrillation
- SEISMIC HF-I - Novel AI to Assess Intracardiac Filling Pressure: The Non-invasive SEISMocardiogram In Cardiovascular Monitoring for Heart Failure I (SEISMIC-HF I) Study
- The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction.
- GLORIOUS - Efficacy of Restrictive versus Liberal Oxygenation in Patients undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement – a randomized clinical trial
- ENBALV - Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early after Surgical Bioprosthetic Valve Replacement: ENBALV trial